Cantel Medical (NYSE:CMN) and North American Science Associates said they agreed to a $13.5 million cash deal for NAMSA’s sterility assurance business, which Cantel said it plans to fold into its Crosstex division. The NAMSA operation, which posted sales of %5.7 million last year, makes biological and chemical indicators designed to monitor the effectiveness of sterilization procedures. […]